Category Archive: 3) Swiss Markets and News

Main Author Investec
Investec
Investec is a distinctive Specialist Bank and Asset Manager. We provide a diverse range of financial products and services to a niche client base in three principal markets, the United Kingdom, South Africa and Australia, as well as certain other geographies. Investec’s strategic goals are motivated by the desire to develop an efficient and integrated business on an international scale through the active pursuit of clearly established core competencies in the group’s principal business areas.
My articlesMy siteAbout meMy books
Follow on:LinkedINTwitterAmazon
Filter archive by: Show All Show only Articles Show only Videos

This Election Is Less Critical Than You Think

2016-08-02

by

George Friedman writes the free weekly column “This Week in Geopolitics” for Mauldin Economics. Subscribe now (http://goo.gl/kmXV65) and get an in-depth view of the forces that will drive events and investors in the next year, decade, or even a century from now. — With the party conventions over, US voters are waking up to what …

Read More »

Global positioning in a post Brexit world

2016-08-01

by

Ryan Friedman, head of the World Axis and Multi-Manager funds at Investec Wealth & Investment, and Patrick Lawlor, senior content editor, discuss what is driving the performance of certain assets globally, how long can this rally last and what the effect has been on the World Axis fund of funds.

Read More »

Swiss stock market rally loses momentum

2016-07-30

by

2016-07-30

The Swiss Market Index and global stock markets failed to extend last week’s rally after the Federal Reserve and Bank of Japan left rates unchanged and gave mixed messages about the global economic outlook.

Read More »

UBS beats profit estimates as CEO pushes ahead with cost cuts

2016-07-29

by

2016-07-29

UBS Group AG beat analysts’ second-quarter profit estimates and said it’s on track to cut costs by 2.1 billion Swiss francs ($2.2 billion) through 2017, with Chief Executive Officer Sergio Ermotti struggling wi...

Read More »

Credit Suisse’s turnaround is working, but vulnerable

2016-07-29

by

2016-07-29

Brought to you by Investec Switzerland. Just a month ago, Credit Suisse CEO Tidjane Thiam and Deutsche Bank CEO John Cryan risked, as one hedge fund manager put it, becoming the dead men walking of European banking as they struggled to shore up their...

Read More »

Sergio Ermotti, UBS-CEO

2016-07-29

by

Trotz überraschend gutem Quartalsergebnis dürfte die UBS ihre Dividende für 2016 nicht erhöhen, wie CEO Sergio Ermotti im Interview sagt. Er äussert sich zudem zur Korruptionsaffäre in Singapur.

Read More »

What’s the policeman doing with that baguette?

2016-07-28

by

Police officers are taking part in the European biennial of contemporary art, “Manifesta”, in Zurich: but not in their normal roles. They are actors in a social experiment. (SRF/swissinfo.ch) — swissinfo.ch is the international branch of the Swiss Broadcasting Corporation (SBC). Its role is to report on Switzerland and to provide a Swiss perspective on …

Read More »

Tidjane Thiam, CEO der Credit Suisse

2016-07-28

by

CS-Chef Thiam über das zweite Quartal.

Read More »

Maps Maponyane takes #Reserved4Me winner for shopping spree

2016-07-28

by

Maps Maponyane, Investec’s brand ambassador, recently took the #Reserved4Me competition winner, Tebogo Rammutla, for a personal styling session. Here are the highlights of the day.

Read More »

George Friedman: The Turkey Coup Dashes the US’ Hopes

2016-07-26

by

George Friedman writes the free weekly column “This Week in Geopolitics” for Mauldin Economics. Subscribe here: http://goo.gl/vhvxME. Each week, you’ll receive an in-depth view of the forces driving events and investors in the next year, decade, or even a century from now.

Read More »

Joe Root on coming in at number 3 and his preparations for batting

2016-07-25

by

Joe Root discusses his preparations ahead of batting at number 3, with Simon Hughes.

Read More »

Investec Ireland: Who we are

2016-07-24

by



Read More »

Swiss markets fluctuate on earnings data

2016-07-22

by

2016-07-22

The Swiss Market Index is set to finish the week slightly higher as investors digest second quarter earnings reports and central bank policy announcements.

Read More »

Roche CEO worried about U.K. drug research following Brexit

2016-07-22

by

2016-07-22

The U.K.’s decision to leave the European Union poses a threat to research and development in the pharmaceutical industry, Roche Holding AG Chief Executive Officer Severin Schwan said. A departure would mean the country would have to set up its own system for approving drugs for sale, a job now done for bloc members by the European Medicines Agency.

Read More »

Börsen-Talk vom 22. Juli 2016

2016-07-22

by

Wie sieht die Zwischenbilanz der Zahlensaison an der Schweizer Börse aus? Können Anleger mit weiteren Kursgewinnen rechnen? Aktien-Experte Thomas Germann von WMPartners gibt im Börsen-Talk Auskunft.

Read More »

Jean-Paul Clozel, CEO Actelion

2016-07-21

by

Nach einem erfolgreichen ersten Halbjahr erwartet Actelion-Chef Jean-Paul Clozel eine weitere Steigerung der Aktie. Optimistisch stimmt ihn die Markteinführung zweier wichtiger Medikamente.

Read More »

Joe Root Masterclass – Trigger Movements

2016-07-20

by

Joe Root discusses his trigger movements in the latest masterclass with ‘The Analyst’ Simon Hughes.

Read More »

George Friedman: Terrorism Fuels Nationalism and Deglobalization of the World

2016-07-20

by

George Friedman writes the free weekly column “This Week in Geopolitics” for Mauldin Economics. Subscribe here: http://goo.gl/fz8LE2. Each week you’ll receive an in-depth view of the forces driving events and investors in the next year, decade, or even a century from now.

Read More »

Givaudan profit beats estimates on U.S. fragrance demand

2016-07-19

by

2016-07-19

Givaudan SA, the world’s largest flavors and fragrance company, reported first-half profit that beat analyst estimates on increased demand for perfumes. Earnings before interest, taxes, depreciation and amortization rose 13 percent to 638 million francs ($649 million), the Vernier, Switzerland-based company said in a statement on Monday. Analysts had predicted 576 million francs. Sales gained 6.2 percent on a like-for-like basis to 2.33 billion...

Read More »

Novartis says profit may drop

2016-07-19

by

2016-07-19

Novartis AG said profit may fall this year as the Swiss drugmaker increases spending on the heart medicine Entresto and faces declining sales of its best-selling cancer treatment Gleevec. Core operating income will either be about the same as 2015 or decline by a percentage in the low single digits at constant exchange rates, Novartis said Tuesday in a statement. Sales will show little change.

Read More »